What is Chongqing Pharscin Pharmaceutical Co., Ltd.'s (002907.SZ) StockRank?

MoatMap's StockRank for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) is 26/100, with a Sell signal. This is a composite score combining Quality (65), Value (21), and Momentum (30) factor ranks across MoatMap's 20,000+ stock universe.

Does Chongqing Pharscin Pharmaceutical Co., Ltd. have an economic moat?

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) has a Quality factor score of 65/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Chongqing Pharscin Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) is Sell, based on a StockRank of 26/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Chongqing Pharscin Pharmaceutical Co., Ltd. in?

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002907.SZ

SELLREMOVE

Chongqing Pharscin Pharmaceutical Co., Ltd. · Healthcare · China · $765M · Avg Vol: $4M/d

StockRank

P/E (TTM)

84.5x

ROE

2.5%

D/E

0.0x

Dividend %

0.6%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Chongqing Pharscin Pharma is a domestic-focused Chinese pharmaceutical firm. It lacks the global regulatory validation, advanced biologics capabilities, and scale required to benefit from the CDMO Pricing Power Cycle, making it a poor fit for our concentrated global book.

COMPANY DESCRIPTION

Chongqing Pharscin Pharmaceutical Co., Ltd. researches, manufactures, and markets Chinese patent medicines and chemical drugs, focusing on cardiovascular, digestive, and respiratory therapeutic areas. The company possesses several proprietary formulations and national essential drugs, which provide a stable market position in China's healthcare system. Its competitive advantage is supported by an established clinical academic promotion network and modern pharmaceutical manufacturing facilities.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	116M	102M	115M	122M	1.8%
EPS	0.04	0.01	0.03	0.02	-13.9%
Shares	418M	418M	418M	418M	0.0%
Debt	25,107	41,672	18,853	6M	526.6%
Equity	238M	239M	245M	250M	1.6%
Op CF	2M	32M	24M	9M	68.3%
Inv CF	-782,200	-23M	-16M	-30M	—
Fin CF	-5M	-4M	-5M	-6M	—

PRICE (1M)-10.6%

SMA 50SMA 200

$1.81

RSI (14)

51.0

52W High

$3.30

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

4.4%55.0

ROE

2.5%49.4

GP/Assets

22.7%51.9

Op. Margin

16.3%76.9

FCF/Assets

4.4%68.4

Piotroski

—83.4

Int. Cover

50.0x91.4

D/E Ratio

0.02x81.5

Current Ratio

4.68x68.5

Value

P/E (TTM)

84.5x11.3

EV/EBITDA

35.4x9.5

P/FCF

391.2x20.2

P/B

2.9x41.8

P/S

6.2x34.9

Div Yield

0.6%17.9

Momentum

52W High %

55%30.3

RS 6M

-31%40.0

SMA 50/200

0.87x26.0

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-19%26.2

FUNDAMENTALS

Market Cap

$765M

P/E (Forward)

—

Gross Margin

57.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002907.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002907.SZ	Chongqing Pharscin Pharmaceutical Co., Ltd.(you)	$765M	26	SELL
688621.SS	Beijing Sun-Novo Pharmaceutical Research Co., Ltd.	$894M	26	SELL
300485.SZ	Beijing Science Sun Pharmaceutical Co., Ltd.	$634M	27	SELL
300702.SZ	Zhejiang Tianyu Pharmaceutical Co., Ltd.	$989M	26	SELL
603567.SS	Heilongjiang ZBD Pharmaceutical Co., Ltd.	$994M	26	SELL
002038.SZ	Beijing SL Pharmaceutical Co., Ltd.	$893M	28	SELL
002940.SZ	Zhejiang AngLiKang Pharmaceutical CO.,LTD.	$1.0B	25	SELL
002793.SZ	Luoxin Pharmaceuticals Group Stock Co., Ltd.	$690M	31	SELL
600422.SS	KPC Pharmaceuticals,Inc.	$999M	24	SELL
6185.HK	CanSino Biologics Inc.	$814M	18	STRONG SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.0%

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) — Stock Score Summary

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) has a MoatMap StockRank of 26/100 based on Quality (65/100), Value (21/100), and Momentum (30/100) factor scores. The current signal is SELL. Chongqing Pharscin Pharma is a domestic-focused Chinese pharmaceutical firm. It lacks the global regulatory validation, advanced biologics capabilities, and scale required to benefit from the CDMO Pricing Power Cycle, making it a poor fit for our concentrated global book.

Key Financial Metrics

Price	$1.81
Market Cap	$765M
P/E (TTM)	84.50
Price/Book	2.87
Return on Equity	2.5%
Return on Invested Capital	4.4%
Debt/Equity	2.36
Gross Margin	57.3%
Operating Margin	16.3%
Revenue Growth	-11.3%
Dividend Yield	0.6%
Free Cash Flow	$2M

Chongqing Pharscin Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Chongqing Pharscin Pharmaceutical Co., Ltd.’s (002907.SZ) StockRank?: MoatMap’s StockRank for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) is 26/100, with a Sell signal. It is a composite of Quality (65), Value (21), and Momentum (30) factor ranks across MoatMap’s 20,000+ stock universe.
Does Chongqing Pharscin Pharmaceutical Co., Ltd. have an economic moat?: Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) has a Quality factor score of 65/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Chongqing Pharscin Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) is Sell, based on a StockRank of 26/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Chongqing Pharscin Pharmaceutical Co., Ltd. in?: Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).